In line with the cooperative role for ERK3 overexpression and PTEN deletion in promoting tumor growth in vivo [41], ERK3 was shown to activate AKT via phosphorylating S473, thereby promoting xenograft tumor growth of both lung cancer cells and breast cancer cells (Figure 2) [44]. Here, MAPK6 is linked to neoplasm.